Ingredion has agreed to acquire Tate & Lyle PLC in a £3.7 billion ($5 billion) deal, subject to shareholder approval and regulatory clearances. The combined company aims to better serve customer needs for healthier and affordable food products, leveraging their complementary ingredient portfolios in texturants, sugar reduction, mouthfeel, and fortification. The deal is expected to generate $130 million in cost savings by 2030 and boost earnings per share in the first year.

The acquisition will be funded through a mix of existing cash and new debt financing, with Ingredion aiming to reduce its debt load within 18 months of completion. Tate & Lyle's board has unanimously recommended the offer to shareholders, highlighting the potential for greater scale, increased innovation, and improved customer support in the future. The transaction is expected to be completed in the second half of 2027, creating new opportunities for both companies and generating significant value for stakeholders.